Vertex Pharmaceuticals Incorporated
METHODS OF CANCER TREATMENT USING AN ATR INHIBITOR

Abstract:

The present disclosure relates to methods of identifying a cancer having sensitivity to an ATR inhibitor compound, and treating subjects with such identified cancers with the ATR inhibitor, particularly in combination with a DNA damaging agent.